Identification of clinically relevant biomarkers of epileptogenesis — a strategic roadmap
- 16 February 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Neurology
- Vol. 17 (4), 231-242
- https://doi.org/10.1038/s41582-021-00461-4
Abstract
Onset of many forms of epilepsy occurs after an initial epileptogenic insult or as a result of an identified genetic defect. Given that the precipitating insult is known, these epilepsies are, in principle, amenable to secondary prevention. However, development of preventive treatments is difficult because only a subset of individuals will develop epilepsy and we cannot currently predict which individuals are at the highest risk. Biomarkers that enable identification of these individuals would facilitate clinical trials of potential anti-epileptogenic treatments, but no such prognostic biomarkers currently exist. Several putative molecular, imaging, electroencephalographic and behavioural biomarkers of epileptogenesis have been identified, but clinical translation has been hampered by fragmented and poorly coordinated efforts, issues with inter-model reproducibility, study design and statistical approaches, and difficulties with validation in patients. These challenges demand a strategic roadmap to facilitate the identification, characterization and clinical validation of biomarkers for epileptogenesis. In this Review, we summarize the state of the art with respect to biomarker research in epileptogenesis and propose a five-phase roadmap, adapted from those developed for cancer and Alzheimer disease, that provides a conceptual structure for biomarker research.Keywords
This publication has 106 references indexed in Scilit:
- Can structural or functional changes following traumatic brain injury in the rat predict epileptic outcome?Epilepsia, 2013
- Animal models of traumatic brain injuryNature Reviews Neuroscience, 2013
- Recording and analysis techniques for high-frequency oscillationsProgress in Neurobiology, 2012
- Finding a better drug for epilepsy: Preclinical screening strategies and experimental trial designEpilepsia, 2012
- Risk Factors for Epilepsy in Children With Neonatal EncephalopathyPediatric Research, 2011
- Preclinical stroke research – advantages and disadvantages of the most common rodent models of focal ischaemiaBritish Journal of Pharmacology, 2011
- High‐frequency oscillations as a new biomarker in epilepsyAnnals of Neurology, 2011
- Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemmaEpilepsia, 2011
- Human Traumatic Brain Injury Alters Plasma microRNA LevelsJournal of Neurotrauma, 2010
- Seizures and Epilepsy After Ischemic StrokeStroke, 2004